BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3500310)

  • 1. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men.
    Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI
    J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement components in Nigerians with bronchial asthma.
    Onyemelukwe GC
    Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA; Strauss LG; Georgi M
    Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of complement in proliferative vitreoretinopathy.
    Grisanti S; Wiedemann P; Weller M; Heimann K; Zilles K
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2711-7. PubMed ID: 1894471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
    Saitoh S; Nakanishi A; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemolytic complement in peripheral lymph of normal men.
    Olszewski WL; Engeset A
    Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of complement components in the course of type I (Lepra) and type II (ENL) reactions.
    Sehgal VN; Sharma V; Sharma VK
    Int J Dermatol; 1989; 28(1):32-5. PubMed ID: 2783924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi.
    Sinha D; Wells M; Faulk WP
    Clin Exp Immunol; 1984 Apr; 56(1):175-84. PubMed ID: 6370518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
    Hoffmeister HM; Fuhrer G; Platten HP; Heller W
    Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immuno-pathological studies on muscles of polymyositis and dermatomyositis].
    Yu MX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):279-82. PubMed ID: 2976316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
    Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
    Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary angioedema: description of a sibship and review].
    Matter L; Schopfer K; Voegelin HP; Fueter R
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1238-45. PubMed ID: 6974398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.